Physicians
Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial
- A phase 3 trial of Kolon TissueGene’s cell-based gene therapy has missed its co-primary endpoints. With a second late-stage study scheduled to report data in October, the biotech is holding off on determining the next st
